GlassScriptPhysician profile
Thomas W Miller
NPI 1669459145
$1,487.55
in general payments reported to CMS, 2019-2025
30 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $107 · 2021: $99.42 · 2022: $210 · 2023: $457 · 2024: $194 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $253.18 | 2023-2025 | Veozah |
| Abbvie INC. | $175.51 | 2019-2021 | |
| Pfizer INC. | $136.13 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $105.65 | 2021-2024 | |
| Mayne Pharma Commercial LLC | $103.48 | 2021-2025 | |
| Amgen INC. | $70.12 | 2023-2024 | Evenity, Prolia |
| Hologic Sales and Service, LLC | $65.74 | 2019-2024 | Acessa Provu System, Myosure Tissue Removal Device |
| Biogen, INC. | $59.39 | 2025 | Zurzuvae |
| Aspira Women'S Health INC | $40.95 | 2022 | |
| Gynesonics, INC. | $39.04 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $35.20 | 2021-2024 | |
| Meditrina | $34.82 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $33.12 | 2025 | |
| Amag Pharmaceuticals, INC. | $29.00 | 2019 | |
| Sumitomo Pharma America, INC. | $25.92 | 2023 | Myfembree |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $24.29 | 2023 | Azstarys |
| Abbott Laboratories | $23.96 | 2024 | Freestyle Libre 3 |
| Exeltis, USA INC. | $22.47 | 2025 | Slynd |
| Coopersurgical, INC. | $22.39 | 2019-2020 | |
| Dexcom, INC. | $21.10 | 2025 | Dexcom G6 Transmitter |
| Myovant Sciences INC. | $20.36 | 2022 | |
| Lupin INC. | $19.74 | 2020 | |
| Exact Sciences Corporation | $18.32 | 2025 | The Cologuard Plus Collection Kit |
| Becton, Dickinson and Company | $17.18 | 2024 | Bd Max System, Bd Max Instrument |
| Merck Sharp & Dohme LLC | $16.81 | 2020 | |
| Ethicon US, LLC | $15.59 | 2019 | |
| Novo Nordisk INC | $15.57 | 2023 | |
| Shield Therapeutics INC | $14.97 | 2023 | Accrufer |
| Boston Scientific Corporation | $14.61 | 2019 | |
| Minerva Surgical, INC | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.